CD8A and cancer: As a result, deletion of <i>Cgas</i> or <i>Sting</i> from <i>Ogt<sup>-/-</sup></i> cancer cells restored tumor growth, and this correlated with impaired CD8<sup>+</sup> T-cell-mediated antitumor immunity.